Financial Performance - The company reported a basic earnings per share of 0.0800 yuan for Q1 2025, a decrease of 57.89% compared to 0.1900 yuan in Q1 2024 and down from 0.3800 yuan in Q1 2023 [1] - The net profit for Q1 2025 was 0.1 billion yuan, reflecting a decline of 54.55% from 0.22 billion yuan in Q1 2024 and down from 0.34 billion yuan in Q1 2023 [1] - The operating revenue for Q1 2025 was 0.47 billion yuan, which is a decrease of 29.85% compared to 0.67 billion yuan in Q1 2024 and down from 1.14 billion yuan in Q1 2023 [1] - The return on equity (ROE) for Q1 2025 was 1.34%, a significant drop of 59.27% from 3.29% in Q1 2024 and down from 6.27% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 49.286 million shares, accounting for 59.55% of the circulating shares, with a decrease of 86,700 shares compared to the previous period [1] - The largest shareholder, Hainan Maisun Investment Partnership, holds 16.0313 million shares, representing 19.37% of the total share capital, with no change in holdings [2] - Other notable shareholders include Zou Qian with 11.5033 million shares (13.90%) and Zou Yang with 6.4199 million shares (7.76%), both showing no change in their holdings [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in the current period [2]
康普化学:2025一季报净利润0.1亿 同比下降54.55%